T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$1.86B |
| 2 |
VMW
VMware, Inc
VMW
|
+$1.49B |
| 3 |
Broadcom
AVGO
|
+$1.29B |
| 4 |
Sempra
SRE
|
+$1.26B |
| 5 |
Booking.com
BKNG
|
+$1.12B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PayPal
PYPL
|
+$1.66B |
| 2 |
HCA Healthcare
HCA
|
+$1.02B |
| 3 |
BNY
Bank of New York Mellon
BNY
|
+$949M |
| 4 |
American Tower
AMT
|
+$931M |
| 5 |
FRC
First Republic Bank
FRC
|
+$890M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.07% |
| 2 | Financials | 16.19% |
| 3 | Technology | 16.15% |
| 4 | Consumer Discretionary | 13.93% |
| 5 | Industrials | 9.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
426
Flowserve
FLS
$10.3B
| $231M | 0.04% |
5,491,762
-1,908,116
| -26% | -$79.9M |
|
427
SLB Ltd
SLB
$79.7B
| $231M | 0.04% |
3,428,848
-123,103
| -3% | -$7.98M |
|
428
Zillow
ZG
$7.71B
| $231M | 0.04% |
5,662,642
-14,398
| -0.3% | -$591K |
|
429
IBM
IBM
$225B
| $230M | 0.04% |
1,569,470
-50,843
| -3% | -$7.39M |
|
|
WMGI
430
DELISTED
Wright Medical Group Inc
WMGI
| $230M | 0.04% |
10,366,976
+748,520
| +8% | +$18.5M |
|
431
Alexandria Real Estate Equities
ARE
$8.28B
| $230M | 0.04% |
1,760,626
-88,436
| -5% | -$11.1M |
|
432
Prothena Corp
PRTA
$473M
| $229M | 0.04% |
6,103,759
+654,868
| +12% | +$33.3M |
|
433
Terreno Realty
TRNO
$7.44B
| $228M | 0.04% |
6,501,905
-90,090
| -1% | -$3.31M |
|
434
Prosperity Bancshares
PB
$8.85B
| $227M | 0.04% |
3,240,833
-5,567
| -0.2% | -$372K |
|
435
PACCAR
PCAR
$69.8B
| $227M | 0.04% |
4,781,432
+714,596
| +18% | +$33.8M |
|
436
Ashland
ASH
$3.42B
| $225M | 0.04% |
3,158,143
+19,427
| +0.6% | +$1.34M |
|
437
Veeva Systems
VEEV
$38.4B
| $223M | 0.04% |
4,033,503
+491,844
| +14% | +$29M |
|
438
Flowers Foods
FLO
$1.52B
| $222M | 0.04% |
11,522,013
-184,669
| -2% | -$3.55M |
|
439
Post Holdings
POST
$3.56B
| $222M | 0.04% |
4,286,019
-162,762
| -4% | -$8.66M |
|
|
VIAB
440
DELISTED
Viacom Inc. Class B
VIAB
| $221M | 0.04% |
7,161,829
-440,230
| -6% | -$12M |
|
441
Novanta
NOVT
$6.34B
| $220M | 0.04% |
4,402,250
+107,584
| +3% | +$5.24M |
|
442
RH
RH
$3.46B
| $219M | 0.04% |
2,535,950
-27,468
| -1% | -$2.48M |
|
443
Ingersoll Rand
IR
$33B
| $218M | 0.04% |
6,424,069
+1,716,378
| +36% | +$51.2M |
|
444
BioMarin Pharmaceuticals
BMRN
$13.5B
| $216M | 0.04% |
2,422,414
+413,363
| +21% | +$35.9M |
|
445
Littelfuse
LFUS
$11.5B
| $216M | 0.04% |
1,091,338
+399,944
| +58% | +$80.2M |
|
446
Carnival Corporation Ltd
CCL
$38B
| $216M | 0.04% |
3,251,299
+145,814
| +5% | +$9.66M |
|
|
HOUS
447
DELISTED
Anywhere Real Estate
HOUS
| $215M | 0.03% |
8,126,188
+1,349,059
| +20% | +$39.1M |
|
|
ONCE
448
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
| $212M | 0.03% |
4,126,961
+304,002
| +8% | +$21.8M |
|
449
Cal-Maine
CALM
$3.87B
| $212M | 0.03% |
4,765,073
+181,145
| +4% | +$8.07M |
|
|
K
450
DELISTED
Kellanova
K
| $210M | 0.03% |
3,291,206
+578,245
| +21% | +$34.8M |
|
Similar funds
T. Rowe Price Associates's Q4 2017 Portfolio in Review
As of Q4 2017, T. Rowe Price Associates held 2,692 positions worth $616B, up 5.3% from $585B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
T. Rowe Price Associates's Q4 2017 filing shows 121 new, 947 increased, 1,282 reduced and 130 closed positions. Its largest new stake was CarGurus: 13,060,603 shares worth $374M. The largest sale was PayPal, an estimated $1.66B.
By sector, the portfolio is most concentrated in Healthcare at 17% of assets, down from 18% a quarter earlier, followed by Financials and Technology.
- T. Rowe Price Associates's largest Q4 2017 buy was CarGurus: 13,060,603 shares worth $374M.
- T. Rowe Price Associates added most to Tesla in Q4 2017, an estimated $1.86B increase.
- T. Rowe Price Associates's biggest Q4 2017 reduction was PayPal, cutting an estimated $1.66B.
- T. Rowe Price Associates fully exited Kite Pharma, Inc. in Q4 2017, selling an estimated $483M.
- T. Rowe Price Associates's ten largest holdings make up 19% of its $616B portfolio in Q4 2017.
- T. Rowe Price Associates opened 121 new positions and closed 130 in Q4 2017.
- T. Rowe Price Associates's portfolio value rose 5.3% quarter-over-quarter to $616B.
Based on T. Rowe Price Associates's 13F filing for Q4 2017, filed 14 Feb 2018.